Quantcast
Connect with us

WATCH: Hillary Clinton and Tim Kaine slam Donald Trump and Mike Pence at first rally

Published

on

Democratic candidate for president Hillary Clinton is taking the stage with vice presidential pick Tim Kaine in south Florida, Saturday.

“Tim Kaine is everything Donald Trump and Mike Pence are not,” Clinton told the audience before introducing her new running mate. “He is qualified to step into this job and lead on Day 1. And he is a progressive who likes to get things done.”

ADVERTISEMENT

“In both of our families, faith wasn’t just something we talked about at church on Sundays, it was a call to serve others in every way that we can,” she continued.

“Make no mistake, behind that smile, Tim also has a backbone of steel. Just ask the NRA,” Clinton said in reference to Kaine’s F rating as Virginia’s governor. “Over and over again he has had the courage to stand up to the gun lobby in their own backyard.”

Kaine was the governor of the state during the Virginia Tech shooting, which he told the crowd was “the worst day of my life.”

“At every stage of Tim’s career, the people who know him best have voted to give him a promotion,” Clinton said of Kaine’s rise through every level of government from municipal, state to federal. “And that’s because he fights for the people he represents and he delivers real results. I can’t wait for all of you to get to know him the way that I have.”

“Bienvenidos a todos,” Kaine said, taking the stage. The phrase translates to “welcome to everyone.” “Somos Americanos todos,” he also said, which translates to, “We are all Americans,” a dig on Trump’s exclusionary, anti-immigrant policies.

ADVERTISEMENT

CNN’s Wolf Blitzer reported on air that commentator Ana Nevarro was surprised by Kaine’s nearly perfect Spanish accent as he spoke to the crowd. Navaro admitted last week that no one short of the Virgin Mary herself could get her to vote for Donald Trump.

“Do you want a trash-talker president or a bridge-builder president?” Kaine said revving up the crowd.

Trump refrained from tweeting during the speech, but sent out a few rapid fire tweets prior to the speech, attacking Kaine on trade issues.

ADVERTISEMENT

Watch below via Fox 5 Atlanta:

ADVERTISEMENT


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

2020 Election

Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report

Published

on

According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.

The report, by the Times' Reid Epstein, begins with one such possible scenario.

Continue Reading

COVID-19

‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint

Published

on

Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.

Continue Reading
 

COVID-19

Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity

Published

on

Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.

Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image